Article Details

NGM Bio Pinpoints Fourth Antibody Drug Candidate for Oncology Therapy Development

Retrieved on: 2021-08-25 19:52:30

Tags for this article:

Click the tags to see associated articles and topics

NGM Bio Pinpoints Fourth Antibody Drug Candidate for Oncology Therapy Development. View article details on hiswai:

Excerpt

NGM Biopharmaceuticals, a US-based biotechnology company, disclosed a fourth ... another potential approach to mobilize a patient's own immune system to ...

Article found on: www.biopharminternational.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up